Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer

The original version of this article unfortunately contained a mistake. The co-authors' names were incorrect.

https://ift.tt/2zJCoLc